ATG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.428200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.035600E-01
Normal-vs-Stage2
4.487600E-01
Normal-vs-Stage3
4.434200E-01
Normal-vs-Stage4
9.234600E-01
Stage1-vs-Stage2
7.430200E-01
Stage1-vs-Stage3
8.976400E-01
Stage1-vs-Stage4
2.538800E-01
Stage2-vs-Stage3
6.789400E-01
Stage2-vs-Stage4
3.144600E-01
Stage3-vs-Stage4
4.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.259000E-01
Normal-vs-AfricanAmerican
9.550400E-01
Normal-vs-Asian
2.876000E-01
Caucasian-vs-AfricanAmerican
3.154800E-01
Caucasian-vs-Asian
5.845200E-01
AfricanAmerican-vs-Asian
2.653200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.110000E-01
Normal-vs-Female
5.055800E-01
Male-vs-Female
4.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.004450E-01
Normal-vs-Age(41-60Yrs)
6.335200E-01
Normal-vs-Age(61-80Yrs)
3.914400E-01
Normal-vs-Age(81-100Yrs)
3.837600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.595400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.210800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.783770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.361580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.684400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.703560E-01
Normal-vs-Daily Drinker
4.057200E-01
Normal-vs-Weekly Drinker
3.976600E-01
Normal-vs-Occasional Drinker
9.237000E-01
Normal-vs-Social Drinker
3.333000E-01
Non Drinker-vs-Daily Drinker
5.904200E-01
Non Drinker-vs-Weekly Drinker
6.888000E-01
Non Drinker-vs-Occasional Drinker
9.853800E-02
Non Drinker-vs-Social Drinker
4.572600E-01
Daily Drinker-vs-Weekly Drinker
9.478000E-01
Daily Drinker-vs-Occasional Drinker
2.344200E-01
Daily Drinker-vs-Social Drinker
8.769200E-01
Weekly Drinker-vs-Occasional Drinker
2.787400E-01
Weekly Drinker-vs-Social Drinker
8.322200E-01
Occasional Drinker-vs-Social Drinker
3.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.053800E-01
Normal-vs-Grade 2
7.379400E-01
Normal-vs-Grade 3
7.570800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.424290E-03
Grade 1-vs-Grade 3
1.619810E-02
Grade 1-vs-Grade 4
9.053800E-01
Grade 2-vs-Grade 3
6.254400E-01
Grade 2-vs-Grade 4
7.379400E-01
Grade 3-vs-Grade 4
7.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.056400E-01
Normal-vs-NonDiabetic
3.387200E-01
Diabetic-vs-NonDiabetic
7.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.070200E-01
Normal-vs-NoPancreatitis
3.815600E-01
Pancreatitis-vs-NoPancreatitis
7.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.750000E-01
Normal-vs-N1
4.622400E-01
N0-vs-N1
9.175400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.619400E-01
Normal-vs-TP53-NonMutant
3.301400E-01
TP53-Mutant-vs-TP53-NonMutant
4.217400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
